15 Biotech Stocks to Buy Now According to Srini Akkaraju and Michael Dybbs’ Samsara BioCapital
In this article, we will discuss 15 biotech stocks to buy now according to Srini Akkaraju and Michael Dybbs' Samsara BioCapital.
Intercept Pharmaceuticals Inc. (ICPT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 57,791,000 | $52,992 | 1.18% | ||
| 2. | Samsara BioCapital Srini Akkaraju And Michael Dybbs | 640,688 | $10,424 | 2.62% | |
| 3. | Two Sigma Advisors John Overdeck And David Siegel | 577,200 | $9,391 | +6% | 0.02% |
| 4. | Millennium Management Israel Englander | 488,266 | $7,944 | -13% | 0% |
| 5. | 6,655,000 | $6,338 | +3% | 0.06% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $21.29 | 147,000 | Director | 640,688 | 2021-03-12 | Filing | |
| $21.55 | 16,559 | Director | 493,688 | 2021-03-10 | Filing | |
| $20.83 | 73,441 | Director | 477,129 | 2021-03-10 | Filing | |
| $60.32 | 5,207 | Director | 403,688 | 2019-08-28 | Filing | |
| $64.30 | 1,180 | Director | 398,481 | 2019-08-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.47 | 2,193 | Officer | 23,764 | 2021-01-05 | Filing | |
| $32.78 | 1,763 | Officer | 27,158 | 2020-12-15 | Filing | |
| $47.44 | 1,192 | Officer | 8,778 | 2020-08-18 | Filing | |
| $46.75 | 1,235,512 | 4,000,000 | 2020-08-17 | Filing | ||
| $50.15 | 126,888 | 5,235,512 | 2020-08-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 25,109 | $408,522 | 0% | |
| 2. | 20,922 | $340,401 | 0% | |
| 3. | 322,000 | $305,476 | 0% | |
| 4. | 3,221,832 | $52,419 | 0% | |
| 5. | 2,655,257 | $43,201 | 0% |
News See All
5 Best Short Squeeze Stocks To Buy Now
Nikola Corporation (NASDAQ:NKLA) is placed fifth on our list of 15 best short squeeze stocks to buy now. The firm engages in the development and integration of transportation and energy solutions.
Hedge Fund and Insider Trading News: Bill Ackman, Mike Novogratz, Sanjay Shah, LIOR Global Partners, Anomaly Capital, Two Sigma Investments, Intercept Pharmaceuticals Inc (ICPT), Kaiser Aluminum Corp. (KALU), and More
Billionaire investor Bill Ackman said Monday he donated his entire stake in Coupang - worth more than $1 billion - to charity following the South Korean e-commerce company’s IPO last week.
5 Underperforming Stocks Targeted By Short Sellers
In this article we discuss top 5 underperforming stocks targeted by short sellers.
Is ICPT A Good Stock To Buy According To Hedge Funds?
At Insider Monkey, we pore over the filings of nearly 817 top investment firms every quarter, a process we have now completed for the latest reporting period.
Hedge Funds Slowly Coming Back To Intercept Pharmaceuticals Inc (ICPT)
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file by the SEC.
Did Hedge Funds Make The Right Call On Intercept Pharmaceuticals Inc (ICPT)?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Is Intercept Pharmaceuticals Inc (ICPT) Going to Burn These Hedge Funds?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Funds Have Never Been This Bullish On Intercept Pharmaceuticals Inc (ICPT)
We hate to say this but, we told you so.
Did Hedge Funds Drop The Ball On Intercept Pharmaceuticals Inc (ICPT) ?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Billionaire Hedge Funds
